Skip to main content
MENU
Subscribe
  • Subscribe
  • Account
  • LOGIN
  • Topics
    • Alternatives
    • Consultants
    • Coronavirus
    • Courts
    • Defined Contribution
    • ESG
    • ETFs
    • Hedge Funds
    • Industry Voices
    • Investing
    • Money Management
    • Opinion
    • Partner Content
    • Pension Funds
    • Private Equity
    • Real Estate
    • Russia-Ukraine War
    • SECURE Act 2.0
    • Special Reports
    • White Papers
  • Rankings & Awards
    • 1,000 Largest Retirement Plans
    • Top-Performing Managers
    • Largest Money Managers
    • DC Money Managers
    • DC Record Keepers
    • Largest Hedge Fund Managers
    • World's Largest Retirement Funds
    • Best Places to Work in Money Management
    • Excellence & Innovation Awards
    • Eddy Awards
  • ETFs
    • Latest ETF News
    • Fund Screener
    • Education Center
    • Equities
    • Fixed Income
    • Commodities
    • Actively Managed
    • Alternatives
    • ESG Rated
  • ESG
    • Latest ESG News
    • The Institutional Investor’s Guide to ESG Investing
    • Climate Change: The Inescapable Opportunity
    • Impact Investing
    • 2022 ESG Investing Conference
    • ESG Rated ETFs
  • Defined Contribution
    • Latest DC News
    • DC Money Manager Rankings
    • DC Record Keeper Rankings
    • Innovations in DC
    • Trends in DC: Focus on Retirement Income
    • 2022 Defined Contribution East Conference
    • 2022 DC Investment Lineup Conference
  • Searches & Hires
    • Latest Searches & Hires News
    • Searches & Hires Database
    • RFPs
  • Performance Data
    • P&I Research Center
    • Earnings Tracker
    • Endowment Returns Tracker
    • Corporate Pension Contribution Tracker
    • Pension Fund Returns Tracker
    • Pension Risk Transfer Database
    • Future of Investments Research Series
    • Charts & Infographics
    • Polls
  • Careers
  • Events
    • View All Conferences
    • View All Webinars
    • 2022 Innovation Investing Conference
    • 2022 Defined Contribution East Conference
    • 2022 ESG Investing Conference
    • 2022 DC Investment Lineup Conference
    • 2022 Alternatives Investing Conference
Breadcrumb
  1. Home
  2. COURTS
March 10, 2021 05:15 PM

Johnson & Johnson prevails in fiduciary-breach suit

Robert Steyer
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Bloomberg

    A U.S. District Court in Newark, N.J., dismissed a complaint by participants in three Johnson & Johnson 401(k) plans, who alleged that plan fiduciaries failed to protect their investments in company stock offered as a plan investment option.

    The participants argued that Johnson & Johnson fiduciaries should have acted following allegations that talc and asbestos had been found in some company products, most notably baby powder, which plaintiffs in product liability cases against Johnson & Johnson have said caused ovarian cancer or mesothelioma. The resulting controversy depressed Johnson & Johnson's stock price.

    On Feb. 26, Chief U.S. District Judge Freda L. Wolfson dismissed a lawsuit representing a consolidation of several baby power-related stock drop complaints in the case of Perrone et al. vs. Johnson & Johnson et al. Plaintiffs were seeking class-action status.

    The judge noted that she had dismissed an original lawsuit in April, but had given plaintiffs the opportunity to file an amended complaint to the initial lawsuit that had been filed in January 2019.

    Referencing her first dismissal, the judge wrote again that plaintiffs' proposals for fiduciaries' response to the baby-powder issue failed to meet the standards set by the U.S. Supreme Court in 2014. The court unanimously, in Fifth Third Bancorp et al. vs. Dudenhoeffer et al., established guidelines for lower courts to determine if a stock-drop complaint should be dismissed or be allowed to go to trial.

    "Plaintiffs acknowledge that in the prior opinion I held that issuing a corrective disclosure was not a viable alternative action under Dudenhoeffer," the judge wrote on Feb. 26. "But they argue that 'given the newly pleaded allegations showing that defendants intentionally linked their securities disclosures with their ERISA-covered fiduciary communications, plaintiffs respectfully submit that the failure to disclose non-public information is subject to ERISA's fiduciary duties in this case.'"

    However, the judge reiterated her reasons for the earlier dismissal. "I find, as I did on the prior motion to dismiss, that issuing a corrective SEC disclosure revealing the alleged truth about the over inflation of J&J stock and/or the asbestos in the company's talc products, is not a viable alternative action because it is not one which could be taken in a fiduciary capacity, but only in a corporate one," she wrote.

    The judge also rejected the plaintiffs' suggestion that Johnson & Johnson fiduciaries could have increased the amount of cash in the 401(k) plans' stock fund to soften the blow of a falling stock price. "Increasing the fund's cash buffer would have triggered a disclosure under both ERISA and the federal securities laws," she wrote. "Further complicating matters, the federal securities laws seemingly would have prevented defendants from making a limited disclosure to only the ERISA plan participants."

    The strategy would have violated the Dudenhoeffer guideline against any corrective fiduciary action that would have done more harm than good, the judge wrote.

    "Defendants would have been required to reveal to the public-at-large that they were doing so, and to explain that they were doing so because the company's stock was artificially inflated and/or that J&J's talc based products contain asbestos," she wrote.

    However, the judge gave the plaintiffs 30 days to file another amended complaint.

    Johnson & Johnson announced in May that it would stop selling talcum-based baby powder in the U.S. and Canada, but it would continue selling a cornstarch-based baby powder.

    "Johnson's Baby Powder represents approximately 0.5% of the total U.S. Consumer Health business," the company's release said. "Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising."

    The statement added that Johnson & Johnson "remains steadfastly confident in the safety of talc-based Johnson's Baby Powder. Decades of scientific studies by medical experts around the world support the safety of our product. We will continue to vigorously defend the product, its safety, and the unfounded allegations against it and the company in the courtroom."

    According to Johnson & Johnson's latest 10-K statement, "the number of pending personal injury lawsuits continues to increase" relating to claims that body powders containing talc, primarily baby powder, cause cancer."

    Most of cases are pending in federal court, organized into a multidistrict litigation in a U.S. District Court in Newark, N.J., said the 10-K statement, filed Feb. 22 with the Securities and Exchange Commission for the fiscal year ended Jan. 3.

    "In talc cases that have previously gone to trial, the company has obtained defense verdicts in a number of them, but there have also been verdicts against the company, many of which have been reversed on appeal," the 10-K statement said.

    Related Articles
    Court tosses stock-drop suit against Johnson & Johnson
    Johnson & Johnson sued for violating ERISA duties in three 401(k) plans
    Recommended for You
    ONLINE_180209828_AR_0_FRAQWKTPAVZW.jpg
    New York sues Albany Diocese over unpaid pension benefits
    ONLINE_190109864_AR_0_SLHVICTSVYPI.jpg
    Former Molina Healthcare employees sue NFP Retirement alleging ERISA violations
    SEClogobig-main.jpg
    Appeals court rules against SEC on administrative law judge proceeding
    OCIO, Anchor in Rough Seas
    Sponsored Content: OCIO, Anchor in Rough Seas

    Reader Poll

    May 23, 2022
    SEE MORE POLLS >
    Sponsored
    White Papers
    Crossroads: Politics, Inflation, & Bonds
    Credit Indices: Closing the Fixed Income Evolutionary Gap
    Forever in Style: Benchmarking with the Morningstar® Broad Style Indexes℠
    Q2 2022 Credit Outlook: Carry On
    Leverage does not equal risk
    Is there a mid-cap gap in your DC plan?
    View More
    Sponsored Content
    Partner Content
    The Industrialization of ESG Investment
    For institutional investors, ETFs can make meeting liquidity needs easier
    Gold: the most effective commodity investment
    2021 Investment Outlook | Investing Beyond the Pandemic: A Reset for Portfolios
    Ten ways retirement plan professionals add value to plan sponsors
    Gold: an efficient hedge
    View More
    E-MAIL NEWSLETTERS

    Sign up and get the best of News delivered straight to your email inbox, free of charge. Choose your news – we will deliver.

    Subscribe Today
    May 23, 2022 page one

    Get access to the news, research and analysis of events affecting the retirement and institutional money management businesses from a worldwide network of reporters and editors.

    Subscribe
    Connect With Us
    • RSS
    • Twitter
    • Facebook
    • LinkedIn

    Our Mission

    To consistently deliver news, research and analysis to the executives who manage the flow of funds in the institutional investment market.

    About Us

    Main Office
    685 Third Avenue
    Tenth Floor
    New York, NY 10017-4036

    Chicago Office
    130 E. Randolph St.
    Suite 3200
    Chicago, IL 60601

    Contact Us

    Careers at Crain

    About Pensions & Investments

     

    Advertising
    • Media Kit
    • P&I Content Solutions
    • P&I Careers | Post a Job
    • Reprints & Permissions
    Resources
    • Subscribe
    • Newsletters
    • FAQ
    • P&I Research Center
    • Site map
    • Staff Directory
    Legal
    • Privacy Policy
    • Terms and Conditions
    • Privacy Request
    Pensions & Investments
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • Topics
      • Alternatives
      • Consultants
      • Coronavirus
      • Courts
      • Defined Contribution
      • ESG
      • ETFs
      • Hedge Funds
      • Industry Voices
      • Investing
      • Money Management
      • Opinion
      • Partner Content
      • Pension Funds
      • Private Equity
      • Real Estate
      • Russia-Ukraine War
      • SECURE Act 2.0
      • Special Reports
      • White Papers
    • Rankings & Awards
      • 1,000 Largest Retirement Plans
      • Top-Performing Managers
      • Largest Money Managers
      • DC Money Managers
      • DC Record Keepers
      • Largest Hedge Fund Managers
      • World's Largest Retirement Funds
      • Best Places to Work in Money Management
      • Excellence & Innovation Awards
      • Eddy Awards
    • ETFs
      • Latest ETF News
      • Fund Screener
      • Education Center
      • Equities
      • Fixed Income
      • Commodities
      • Actively Managed
      • Alternatives
      • ESG Rated
    • ESG
      • Latest ESG News
      • The Institutional Investor’s Guide to ESG Investing
      • Climate Change: The Inescapable Opportunity
      • Impact Investing
      • 2022 ESG Investing Conference
      • ESG Rated ETFs
    • Defined Contribution
      • Latest DC News
      • DC Money Manager Rankings
      • DC Record Keeper Rankings
      • Innovations in DC
      • Trends in DC: Focus on Retirement Income
      • 2022 Defined Contribution East Conference
      • 2022 DC Investment Lineup Conference
    • Searches & Hires
      • Latest Searches & Hires News
      • Searches & Hires Database
      • RFPs
    • Performance Data
      • P&I Research Center
      • Earnings Tracker
      • Endowment Returns Tracker
      • Corporate Pension Contribution Tracker
      • Pension Fund Returns Tracker
      • Pension Risk Transfer Database
      • Future of Investments Research Series
      • Charts & Infographics
      • Polls
    • Careers
    • Events
      • View All Conferences
      • View All Webinars
      • 2022 Innovation Investing Conference
      • 2022 Defined Contribution East Conference
      • 2022 ESG Investing Conference
      • 2022 DC Investment Lineup Conference
      • 2022 Alternatives Investing Conference